Effect of Betaine and Choline on Metabolic Health

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

34 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-01-31

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research is to determine whether extra betaine and choline influence metabolic health in adults with overweight and obesity.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Acute Medium Chain Triglycerides (MCT) Intake in Young and Older Participants

NCT03830268

Ketonemia

COMPLETED NA

Plasma TMAO and Choline Levels in Individuals With Metabolic Syndrome - Comparison Between Eggs and Choline Supplement.

NCT03877003

Coronary Artery Disease Diabetes Metabolic Syndrome

COMPLETED NA

Assessment of TMAO Formation With Egg Intake Versus Choline Supplement in a Healthy Population

NCT03142763

Cardiovascular Risk Factor

COMPLETED NA

Egg Intake, Metabolic Outcomes and Choline Levels

NCT06687122

Obesity and Obesity-related Medical Conditions

RECRUITING NA

Choline and Cardiometabolic Health

NCT04764162

Cardiovascular Risk Factor

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Betaine (N,N,N-trimethylglycine or also glycine betaine) is a derivative of choline that functions as an organic osmolyte and participates in one-carbon metabolism as a methyl donor. Betaine is naturally found in beets, wheat and spinach and sold as a food supplement without prescription. Choline is recognized as an essential nutrient that is found in various foods including eggs, nuts and beef, with the major form of choline in food found as phosphatidylcholine. In addition to being oxidized to the methyl donor betaine, choline is a precursor of several compounds involved in neurotransmitter synthesis, lipid metabolism and transport as well as the structural integrity and signaling of cell membranes. Previous studies have reported alterations in one-carbon metabolites in response to a single meal containing different forms of choline, with interindividual variability dependent on genetics and gut microbiota composition. This study will extend to longer-term impact of different forms of choline (betaine as oxidized choline and choline provided from food) with a focus on overweight and obesity, which comprise a predominant portion of the population in North America. The objective of this study is to determine the effect of betaine supplementation with or without food-form choline (eggs) on metabolic health in adults with overweight and obesity. A randomized crossover study design will be employed, which men and women of age 18-70 years with BMI 25-35 kg/m2 will participate in a 14-week study consisting of three 4-week dietary periods: 1) daily consumption of 3 grams of betaine supplement with no eggs; 2) daily consumption of 3 grams of betaine supplement with 3 whole eggs; and 3) daily consumption of 3 grams of cellulose supplement with no eggs, in a random order, each dietary period separated by a 1-week washout break. Blood, urine and fecal samples as well as anthropometric measurements will be collected at baseline, then at weeks 4, 9 and 14. The collected biological samples will be used to measure glucose and lipid markers, one-carbon metabolites and profiling of gut microbiota and genotype to determine interindividual differences in metabolism.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity and Obesity-related Medical Conditions

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Supplements will be double-blinded, which the order of dietary periods will not be revealed to participants until after the study is completed. Care provider, investigator and outcomes assessor who will be involved in collecting study data will not know the supplement assignment.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Daily 3 whole eggs with daily supplement containing 3 g trimethylglycine

Group Type EXPERIMENTAL

Trimethylglycine

Intervention Type DIETARY_SUPPLEMENT

Betaine anhydrous from sugar beets

Eggs

Intervention Type OTHER

3 whole eggs

Experimental: No eggs with daily supplement containing 3 g trimethylglycine

Group Type EXPERIMENTAL

Trimethylglycine

Intervention Type DIETARY_SUPPLEMENT

Betaine anhydrous from sugar beets

Placebo Comparator: No eggs with daily supplement containing 3 g cellulose

Group Type PLACEBO_COMPARATOR

Cellulose

Intervention Type DIETARY_SUPPLEMENT

Cellulose

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Trimethylglycine

Betaine anhydrous from sugar beets

Intervention Type DIETARY_SUPPLEMENT

Eggs

3 whole eggs

Intervention Type OTHER

Cellulose

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female participant of any race or ethnicity between 18-70 years of age (inclusive) at the time of informed consent
* BMI between 25-35 kg/m2
* Non-smoker
* Willing to consume 3 eggs per day for one dietary period of 4 weeks
* Willing to avoid eggs during the rest of the study including washout period breaks except for eggs that are provided
* Willing to fast before the baseline and dietary period lab visits
* Willing to provide a 24-hr prior day food record at the dietary period lab visits
* Willing to provide or collect biological specimen samples at the baseline and dietary period lab visits
* Willing to follow the study protocol including maintaining usual lifestyle during the entire study

Exclusion Criteria

* Male or female \< 18 years or \> 70 years of age at the time of consent
* BMI \< 25 kg/m2; or BMI \> 35 kg/m2
* Pregnant or planning to become pregnant during the course of the study; currently breastfeeding or postpartum \< 6 months
* Use of hormone therapy including birth control pills
* Follows a vegan diet
* Current smoker (any form of nicotine, e-cigarettes, etc)
* Use of recreational drugs (may affect metabolic pathway for choline)
* Presence of chronic illnesses, e.g., heart disease, diabetes, cancer, celiac disease, inflammatory bowel disease (Crohn's disease and ulcerative colitis), gastrointestinal liver or kidney diseases or alcoholism
* Diagnosis of trimethylaminuria (genetic disorder affecting choline use in body)
* Use of antibiotics in the last 2 months
* Use of prebiotics, probiotics or dietary fiber (i.e., Metamucil) supplements in the last 2 months
* Have allergies to eggs or any anaphylactic food allergies
* Have a schedule or lifestyle patterns incompatible with the study protocol

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes